“None of it was especially easy”: improving COVID-19 vaccine equity for people with disabilities

Sebring, Jennifer C H; Capurro, Gabriela; Kelly, Christine; Jardine, Cynthia G.; Tustin, Jordan; Driedger, S. Michelle

doi:10.17269/s41997-022-00621-z

Cited by 16 publications

(13 citation statements)

References 18 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For some respondents, this could be related to concerns around vaccine service accessibility; approximately 8% of survey respondents indicated that improved vaccine service accessibility for all abilities would be important for making vaccination easier. To ensure those who plan to receive additional vaccine doses are able to act on their intentions, and facilitate uptake in those who are undecided, vaccine services must consider the needs of all abilities [27], and involve those who live with disabilities in service planning [28]. Improved understanding of potential barriers to vaccine uptake in this population is also required [29].…”

Section: Discussionmentioning

confidence: 99%

Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey

et al. 2022

View full text Add to dashboard Cite

Background Additional doses of COVID-19 vaccine have been proposed as solutions to waning immunity and decreased effectiveness of primary doses against infection with new SARS-CoV-2 variants. However, the effectiveness of additional vaccine doses relies on widespread population acceptance. We aimed to assess the acceptance of additional COVID-19 vaccine doses (third and annual doses) among Canadian adults and determine associated factors. Methods We conducted a national, cross-sectional online survey among Canadian adults from October 14 to November 12, 2021. Weighted multinomial logistic regression analyses were used to identify sociodemographic and health-related factors associated with third and annual dose acceptance and indecision, compared to refusal. We also assessed influences on vaccine decision-making, and preferences for future vaccine delivery. Results Of 6010 respondents, 70% reported they would accept a third dose, while 15.2% were undecided. For annual doses, 64% reported acceptance, while 17.5% were undecided. Factors associated with third dose acceptance and indecision were similar to those associated with annual dose acceptance and indecision. Previous COVID-19 vaccine receipt, no history of COVID-19 disease, intention to receive an influenza vaccine, and increasing age were strongly associated with both acceptance and indecision. Chronic illness was associated with higher odds of acceptance, while self-reported disability was associated with higher odds of being undecided. Higher education attainment and higher income were associated with higher odds of accepting additional doses. Minority first language was associated with being undecided about additional doses, while visible minority identity was associated with being undecided about a third dose and refusing an annual dose. All respondents reported government recommendations were an important influence on their decision-making and identified pharmacy-based delivery and drop-in appointments as desirable. Co-administration of COVID-19 and influenza vaccines was viewed positively by 75.5% of the dose 3 acceptance group, 12.3% of the undecided group, and 8.4% of the refusal group. Conclusions To increase acceptance, targeted interventions among visible minority and minority language populations, and those with a disability, are required. Offering vaccination at pharmacies and through drop-in appointments are important to facilitate uptake, while offering COVID-19/influenza vaccine co-administration may have little benefit among those undecided about additional doses.

show abstract

Section: Discussionmentioning

confidence: 99%

Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Patients with physical disabilities, homebound or bedbound, may have been unable to go to the vaccination centers. Physical access to vaccination clinics has been identified as a potential barrier to COVID-19 vaccination ( 41 ). Arranging transportation and other infrastructural enhancement at the vaccination sites are recommended to improve accessibility to people with disabilities ( 41 ).…”

Section: Discussionmentioning

confidence: 99%

“…Physical access to vaccination clinics has been identified as a potential barrier to COVID-19 vaccination ( 41 ). Arranging transportation and other infrastructural enhancement at the vaccination sites are recommended to improve accessibility to people with disabilities ( 41 ). The Singapore government organized outreach programmes like mobile vaccination teams and home vaccination schemes to address limitations to access ( 42 , 43 ).…”

Section: Discussionmentioning

confidence: 99%

A multidisciplinary effort to increase COVID-19 vaccination among the older adults

Moosa

Wee

Jaw

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundCOVID-19 vaccination significantly reduces the risk of infection and its associated morbidity and mortality. However, poor uptake of the COVID-19 vaccination was reported among the high-risk group of older people amidst emerging variants of concern. This community case study reports an outreach program in Singapore, COVE (COVID-19 Vaccination for the Elderly) initiated by healthcare workers in a cluster of primary care clinics. They assessed the vaccine hesitancy among these older persons, addressed their concerns and facilitated their vaccination appointment during a brief phone conversation.MethodTwenty one thousand six hundred and sixty three unvaccinated adults aged ≥60 years were contacted by healthcare worker volunteers over two phases from June to October 2021. In phase I, they contacted adults aged above 70 years over 2 weeks. Adults who were uncontactable in phase I and those aged 60–69 years were sent SMS in phase II. Data were analyzed via descriptive data analysis.ResultsAfter phase 1, 65.5% (n = 5,646/8,617) of older adults had received at least one dose of the COVID-19 vaccine. The respondents expressed intention to vaccinate (39%, n = 3,390), requested to seek further information (25%, n = 2,138), reported access barrier (8%, n = 715), or were concerned of the vaccine adverse effects (3%, n = 288). Vaccination was refused by 24% (n = 2,086) of the respondents. Eventually 60.4% (n = 13,082/21,663) of them were vaccinated 3 months after COVE implementation.ConclusionThe COVE program increased the COVID-19 vaccination uptake of older adults from 84.6 to 96.3%. A person-centric proactive approach by healthcare workers addressed vaccine hesitancy and optimized vaccination. The outreach scheduling of vaccination appointments is key in promoting vaccination uptake among older adults.

show abstract

“…To ensure those who plan to receive additional vaccine doses are able to act on their intentions, and facilitate uptake in those who are undecided, vaccine services must consider the needs of all abilities (27), and involve those who live with disabilities in service planning. (28) Improved understanding of potential barriers to vaccine uptake in this population is also required. (29) Our results indicated both concerning and encouraging relationships between sociodemographic factors and additional vaccine dose acceptance.…”

Section: Discussionmentioning

confidence: 99%

Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey

Reifferscheid

Lee

MacDonald

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Additional doses of COVID-19 vaccine have been proposed as solutions to waning immunity and decreased effectiveness of primary doses against infection with new SARS-CoV-2 variants. However, the effectiveness of additional vaccine doses relies on widespread population acceptance. We aimed to assess the acceptance of additional COVID-19 vaccine doses (third and annual doses) among Canadian adults and determine associated factors. Methods: We conducted a national, cross-sectional online survey among Canadian adults from October 14 to November 12, 2021. Weighted multinomial logistic regression analyses were used to identify sociodemographic and health-related factors associated with third and annual dose acceptance and indecision, compared to refusal. We also assessed influences on vaccine decision-making, and preferences for future vaccine delivery. Results: Of 6010 respondents, 70% reported they would accept a third dose, while 15.2% were undecided. For annual doses, 64% reported acceptance, while 17.5% were undecided. Factors associated with third dose acceptance and indecision were similar to those associated with annual dose acceptance and indecision. Previous COVID-19 vaccine receipt, no history of COVID-19 disease, intention to receive an influenza vaccine, and increasing age were strongly associated with both acceptance and indecision. Chronic illness was associated with higher odds of acceptance, while self-reported disability was associated with higher odds of being undecided. Higher education attainment and higher income were associated with higher odds of accepting additional doses. Minority first language was associated with being undecided about additional doses, while visible minority identity was associated with being undecided about a third dose and refusing an annual dose. All respondents reported government recommendations were an important influence on their decision-making and identified pharmacy-based delivery and drop-in appointments as desirable. Co-administration of COVID-19 and influenza vaccines was viewed positively by 75.5% of the dose 3 acceptance group, 12.3% of the undecided group, and 8.4% of the refusal group. Conclusions: To increase acceptance, targeted interventions among visible minority and minority language populations, and those with a disability, are required. Offering vaccination at pharmacies and through drop-in appointments are important to facilitate uptake, while offering COVID-19/influenza vaccine co-administration may have little benefit among those undecided about additional doses.

show abstract

“None of it was especially easy”: improving COVID-19 vaccine equity for people with disabilities

Cited by 16 publications

References 18 publications

Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey

Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey

A multidisciplinary effort to increase COVID-19 vaccination among the older adults

Transition to Endemic: Acceptance of Additional COVID-19 Vaccine Doses Among Canadian Adults in A National Cross-Sectional Survey

Contact Info

Product

Resources

About